Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
Management Spotlight with Laura Mason
Discover more about our team. In this Spotlight, meet our Director of Pharmaceutical Sciences, Laura Mason, on her journey with Upperton.
Upperton Pharma Solutions Named Champion Award Winner in 2025 CDMO Leadership Awards
Upperton is proud to announce its recognition as the Champion Award Winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.
Upperton Announced as ‘Excellence in Innovation’ Finalist in Medilink Midlands Business Awards 2025
We are delighted to share that we have been shortlisted as a finalist in the Excellence in Innovation category at the Medilink Midlands Business Awards 2025.
How CDMOs Drive CMC Success in Drug Development
Addressing CMC considerations early in the drug development process is vital in the successful creation of a pharmaceutical product.
CMC Considerations for Early-Stage Drug Development
Addressing CMC considerations early in the drug development process is vital in the successful creation of a pharmaceutical product.
What is CMC in Pharmaceutical Development?
CMC refers to the set of activities that ensure a drug product is consistently produced, controlled, and meets the required quality standards.
CMC in the Drug Development Process
Without a strong CMC strategy, even a promising drug candidate can fail to reach the market. Discover the foundation for product development.
Navigating CMC Regulatory Requirements in the Drug Development Process
The CMC section of a regulatory submission is essential as it ensures that the final product can be manufactured consistently and reliably.
Upperton Pharma Solutions Named Winner in 2025 CDMO Leadership Awards
Upperton is proud to announce its selection as a winner in the Small Molecule Dosage Form category at the CDMO Leadership Awards.